Stock screenerAll disclosures →
EDGAR →
LONA
Conviction 0HealthcareScan · Thu, Jun 25, 2026Bullish marubozu
LONA$8.73+1.57%
ResistanceSupportVol 14Vol MA14 12.82K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price8.73
Change+1.57%
Gap-4.42%
Rel volume0.18×
Avg volume14.55K
Avg $ vol124.48K
SMA 208.60
SMA 509.16
SMA 200—
Price vs 50-4.74%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 9.98
RSI (14)49
MACD hist0.04
MACD crossbull · 1d
Stoch %K / %D59 / 48
ADX (14)11
+DI / −DI22 / 19
RSI divergence—
MACD divergenceBullish
ATR %+7.44%
ADR %6.31%
52w high11.68
52w low4.34
From 52w high-25.30%
Above 52w low+101.04%
New 52w highNo
SqueezeOn · 2d
Bollinger width20.62%
%B0.57
Donchian pos40.96%
Donchian high10.05
Donchian low7.81
AVWAP (52w high)9.83
vs AVWAP high-11.20%
AVWAP (52w low)8.75
vs AVWAP low-0.30%
OBV trendDown
Chaikin MF (20)-0.45
Today vs 20d0.18×
Avg vol (14d)12.82K
Avg vol (20d)14.55K
Avg $ vol (20d)124.48K
Market cap81.96M
RS 3m (vs SPY)-17.02%
RS 6m (vs SPY)—
RS line new highNo
Trend template—
Technical rank33.8
1 week+6.01%
1 month-9.77%
3 months-3.38%
6 months—
1 year—
YTD+33.21%
P/E-0.78
P/B1.66
P/S—
P/FCF-1.79
EPS-24.70
Div yield—
ROE-214.20%
ROA-147.52%
Debt/Eq—
Current10.38
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-8.94%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value49.13M
Revenue—
Net income-32.95M
Gross profit—
Free cash flow-45.76M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out9.39M
Employees19
ListedFri, Sep 18, 2020
Free float6.17M
Float %66.1%
Short interest56.59K
Days to cover1.2d
Short volume32.8%
Squeeze score8 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$1.90 · 1 est
Last EPS vs est−$1.73
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank33.8 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish marubozu
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LONA
No recent disclosed trades by Congress in LONA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LONA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Callori Fred Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 2.33K | — | 2026-06-23 | 2026-06-24 |
Callori Fred Director · Stock Option (Right to Buy) · 2026-05-05 | Grant | 56K | $0 | 2026-05-05 | 2026-05-07 |
Silverman Peter B. Director · Stock Option (Right to Buy) · 2026-05-05 | Grant | 56K | $0 | 2026-05-05 | 2026-05-07 |
Holles Natalie C. Director · Stock Option (Right to Buy) · 2026-05-05 | Grant | 56K | $0 | 2026-05-05 | 2026-05-07 |
San Martin Javier CHIEF MEDICAL OFFICER · Stock Option (Right to Buy) · 2026-04-09 | Grant | 350K | $0 | 2026-04-09 | 2026-04-13 |
Romano Kelly A Director · Stock Option (Right to Buy) · 2026-04-09 | Grant | 28K | $0 | 2026-04-09 | 2026-04-13 |
Litton Mark James PRESIDENT and CEO · Stock Option (Right to Buy) · 2026-04-09 | Grant | 750K | $0 | 2026-04-09 | 2026-04-13 |
Renninger Robert CHIEF FINANCIAL OFFICER · Stock Option (Right to Buy) · 2026-04-09 | Grant | 300K | $0 | 2026-04-09 | 2026-04-13 |
JOHNSON JAMES A Director · Stock Option (Right to Buy) · 2026-04-09 | Grant | 28K | $0 | 2026-04-09 | 2026-04-13 |
FLUKE JOHN M JR Director · Stock Option (Right to Buy) · 2026-04-09 | Grant | 28K | $0 | 2026-04-09 | 2026-04-13 |
SEC filings
EDGAR filings in LONA · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.